ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 2604

$753K Total Retail Price of All Prescriptions

Rank: 57 out of 2604

480 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 3,661 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 437 181 1 2
OMEPRAZOLE 402 191 2 5
HYDROCODONE-ACETAMINOPHEN 324 85 S3 3 1
LEVOTHYROXINE SODIUM 278 134 4 4
LISINOPRIL 269 113 5 3
ZOLPIDEM TARTRATE 194 94 6 21
METFORMIN HCL 184 75 7 7
GABAPENTIN 180 45 8 12
ATORVASTATIN CALCIUM 160 96 9 19
HYDROCHLOROTHIAZIDE 140 66 10 10
ATENOLOL 139 69 11 11
FUROSEMIDE 135 69 12 8
WARFARIN SODIUM 128 65 13 13
CYCLOBENZAPRINE HCL 122 22 R 14 43
NEXIUM 118 0 15 53
TRAMADOL HCL 117 37 16 15
AMLODIPINE BESYLATE 112 66 17 6
METOPROLOL TARTRATE 107 69 18 9
CITALOPRAM HBR 103 30 19 18
LANTUS SOLOSTAR 91 34 20 84
ADVAIR DISKUS 89 23 21 41
MELOXICAM 85 33 22 36
FLUOXETINE HCL 84 24 23 49
SPIRIVA 84 24 23 45
ESCITALOPRAM OXALATE 84 33 23 73
POTASSIUM CHLORIDE 83 62 26 16
SERTRALINE HCL 83 57 26 23
TAMSULOSIN HCL 82 48 28 30
CARVEDILOL 82 48 28 26
CYMBALTA 80 22 30 44
METHADONE HCL 79 13 S2 31 67
PROAIR HFA 79 17 31 27
FENTANYL 73 26 S2 33 48
LOSARTAN POTASSIUM 68 39 34 20
TRAZODONE HCL 68 27 34 46
ALENDRONATE SODIUM 64 53 36 29
FLUTICASONE PROPIONATE 60 14 37 31
PEN NEEDLE 60 36 37 145
SPIRONOLACTONE 59 19 39 78
POLYETHYLENE GLYCOL 3350 58 17 40 42
METOPROLOL SUCCINATE 57 47 41 17
IBUPROFEN 52 18 42 32
BUMETANIDE 50 44 43 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.